ep. 37 patients as partners: a winning strategy for drug development
Published 2 months ago • 35 plays • Length 24:25Download video MP4
Download video MP3
Similar videos
-
26:42
ep. 36 rare diseases, real lives: bridging patient needs and drug development
-
22:46
ep. 35 real-world evidence and putting patients at the center of drug development
-
1:05:11
the future of clinical trials: how patient engagement is driving change
-
50:02
roadmap drug development 101 - our pursuit of a cure for psc: patients as pillars of clinical trials
-
18:27
kill ‘patient centricity’ – the ethical requirement to involve patients as partners
-
20:37
podcast ep 8 - exiles, managers and firefighters in ifs therapy
-
59:20
inside the issue: optimizing the diagnosis and treatment of neuroendocrine tumors
-
28:55
patient advocacy advancing breakthrough science and community engagement
-
59:46
new findings on inequities in rare diseases: how they impact research and clinical trials processes
-
18:54
#67 barriers and facilitators to clinician wellbeing
-
4:54
#dialogueforpatientcare: patients at the center of research
-
4:59
national health council – patient engagement in drug development
-
37:51
rare drug development symposium: patient spotlight & fireside chat
-
1:27:51
peof 2020 - involving patients in clinical outcome assessments strategy and development by pfmd
-
5:09
patients matter: giving patients a seat at the table
-
46:10
measuring outcomes that matter to patients
-
1:33
role of patient groups in drug development
-
0:37
revolutionary drug formulation: meeting patients' needs with syrup solution
-
57:00
overview of scientific als landscape and accelerating access to critical therapies for als act
-
5:32
why patient advocacy matters